Forte Biosciences
FBRX
FBRX was delisted on the 26th of August, 2026.
42 hedge funds and large institutions have $155M invested in Forte Biosciences in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
180% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 5
48% more capital inflows, than outflows
Capital inflows: $17.7M | Capital outflows: $11.9M
27% more funds holding
Funds holding: 33 → 42 (+9)
4.3% more ownership
Funds ownership: 78.9% → 83.2% (+4.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
33% less call options, than puts
Call options by funds: $2K | Put options by funds: $3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$6.49M |
| 2 |
AIC
AWM Investment Company
New York
|
+$3.02M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.81M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$919K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$805K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BVF Inc
San Francisco,
California
|
-$6.02M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.03M |
| 3 |
HCM
Heights Capital Management
San Francisco,
California
|
-$1.85M |
| 4 |
Perceptive Advisors
New York
|
-$882K |
| 5 |
Boothbay Fund Management
New York
|
-$758K |
FBRX Hedge Fund Activity: Q3 2025 in Review
42 of the 7,647 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q3 2025, worth a combined $155M — up 22% from $127M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new FBRX positions and 4 closed out — a net gain of 9 holders — while 14 added to existing stakes and 5 trimmed.
The largest buyer was Federated Hermes, adding an estimated $6.49M. The largest seller was BVF Inc, cutting an estimated $6.02M.
- 42 institutional investors held Forte Biosciences (FBRX) as of Q3 2025, up from 33 in Q2 2025.
- Funds reported $155M of Forte Biosciences stock for Q3 2025, up 22% quarter-over-quarter.
- 13 funds opened new Forte Biosciences positions in Q3 2025 and 4 closed out, a net change of +9 holders.
- The largest Forte Biosciences buyer in Q3 2025 was Federated Hermes, an estimated $6.49M added.
- The largest Forte Biosciences seller in Q3 2025 was BVF Inc, an estimated $6.02M sold.
Based on aggregated 13F filings for Q3 2025.